Twitter Facebook LinkedIn YouTube

Latest Video

Invictus MD Strategies (CSE: IMH) entered binding LOI to acquire 100% of PlanC BioPharm

Video Platform Video Management Video Solutions Video Player

Invictus MD Strategies has entered into a binding letter of intent to acquire 100% of a late stage applicant under the Access to Cannabis for Medical Purposes Regulations. PlanC Bio Pharm is currently in active final review stage with Health Canada for an application that was submitted in 2014.